Lidocaine as an Anesthetic Adjuvant in Liver and Gastric Laparoscopic Surgery
Pain, Postoperative
About this trial
This is an interventional treatment trial for Pain, Postoperative
Eligibility Criteria
Inclusion Criteria:
- Men and women over 18 years of age scheduled for gastric or liver cancer surgery through a laparoscopic approach at the University of Girona Dr Josep Trueta.
- Accept and sign the informed consent
Exclusion Criteria:
- decline participating in the study at any stage of its development.
- History of allergic or adverse reactions to Amide-type anesthetics.
- Pregnancy or lactation period
- Diagnosis of Child-Pugh stage B or C liver failure.
- Acute renal failure (GFR <60 ml / min).
- Concomitant treatment with opioids for chronic pain.
- Any condition that, in the clinical judgment of the researchers, may interfere with the object of the research.
Sites / Locations
- Hospital Dr Josep TruetaRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
LIDOCAINE
PLACEBO
2% lidocaine will be administered as a bolus during anesthetic induction equivalent to 1.5 mg / kg of lidocaine. After induction, an intravenous infusion will be started at 0.1 ml / kg / h of the study preparation, equivalent to 2mg / kg / h of lidocaine. The study medication will be prepared in a 20 ml syringe for induction and two 50 ml syringes for anesthetic maintenance containing 2% Lidocaine as assigned by the patient. The syringes prepared by the pharmacy will be identical in all cases, with a label specifying the title of this test and the identification number of the patient
0.9% physiological saline will be used as placebo, and it will be administered as a bolus during anesthetic induction . After induction, an intravenous infusion will be started at 0.1 ml / kg / h of the study preparation, equivalent to 2mg / kg / h of lidocaine/placebo. The study medication will be prepared in a 20 ml syringe for induction and two 50 ml syringes for anesthetic maintenance containing Physiological Serum as assigned by the patient. The syringes prepared by the pharmacy will be identical in all cases, with a label specifying the title of this test and the identification number of the patient